Periferik Sinir Sistemi ve Herediter Nöropatiler
Özet
Periferik sinir sistemi hastalıkları, merkezi sinir sistemi ile vücudun geri kalanı arasındaki iletişimin motor, duysal veya otonom liflerdeki hasar sonucu bozulmasıyla ortaya çıkar. Hastalıklar, genetik geçişli herediter formlar ve metabolik, inflamatuar veya toksik nedenlere bağlı gelişen edinsel formlar olarak iki temel grupta sınıflandırılır. Tanı sürecinde klinik muayene ve elektronöromiyografi (ENMG) temel belirleyicilerken, tedavi stratejileri altta yatan nedene yönelik etiyolojik yaklaşım ve semptomatik destekleyici bakım üzerine kuruludur.
Peripheral nervous system disorders arise from the disruption of motor, sensory, or autonomic communications between the central nervous system and the rest of the body. These conditions are primarily classified into hereditary forms linked to genetic factors and acquired forms resulting from metabolic, inflammatory, or toxic causes. Diagnostic evaluation relies heavily on clinical assessment and electromyography (EMG), while therapeutic management focuses on addressing the underlying etiology alongside supportive care.
Referanslar
Snell RS. Clinical Neuroanatomy. 7th
Blumenfeld H. Neuroanatomy Through Clinical Cases. Sinauer Associates; 2002.
Brazis PW, Masdeu J, Biller J. Localization in Clinical Neurology. 6th ed. Lippincott Williams &Wilkins;
Biller J, Gruener G, Brazis P. DeMyer's The Neurologic Examination: A Programmed Text. 6th ed.
O'Brien M. Aids to the Examination of the Peripheral Nervous System. 5th ed. Saunders Elsevier; 2010.
Jose Biller. Practical Neurology. 4th. Lippincott Williams and Wilkins;
Watson JC, Dyck PJB. Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. Mayo Clin Proc. 2015;90:940-951.
Levine TD, Saperstein DS. Laboratory evaluation of peripheral neuropathy. Neurol Clin 2013;31(02):363–376
Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review. JAMA Neurol 2015;72(12):1510–1518
Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med 2012;172(02):127–132
Siao P, Kaku M. A Clinician's Approach to Peripheral Neuropathy. Semin Neurol. 2019 Oct;39(5):519-530.
Barohn RJ, Amato AA. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin. 2013;31:343-61
Murphy SM, Laura M, Fawcett K et al. (2012a).Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosur Psychiatry 83: 706–710.
Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011; 69:22.
Landrieu P, Baets J (2013). Early onset (childhood) monogenic neuropathies. Handb Clin Neurol 115: 863–891.
Pisciotta C, Shy ME. Neuropathy. Handb Clin Neurol. 2018;148:653-665.
Katona I, Weis J. Diseases of the peripheral nerves. Handb Clin Neurol. 2017;145:453-474.
King R (2014). Hereditary sensory and autonomic neuropathy. In: JM Vallat, J Weis (Eds.), Peripheral nerve disorder. Pathology and genetics. Wiley Blackwell, Chichester)
Fridman V, Reilly MM. Inherited Neuropathies. Semin Neurol 2015;35:407-423.
Incecik F, Herguner OM, Ceylaner S, et al. Giant axonal disease: Report of eight cases. Brain Dev 2015; 37:803.
Johnson-Kerner BL, Roth L, Greene JP, Wichterle H, Sproule DM. Giant axonal neuropathy: An updated perspective on its pathology and pathogenesis. Muscle Nerve 2014; 50:467-476
Erol I, Alehan F, Alkan O, Bruno C. Involvement of the globus pallidus in giant axonal neuropathy. PediatrNeurol 2012;47:382-384
Klein CJ, Duan X, Shy ME. Inherited neuropathies: clinical overview and update. Muscle Nerve 2013; 48:604-622
Tsang SH, Sharma T. Inborn Errors of Metabolism: Refsum Disease. Adv Exp Med Biol. 2018;1085:191-192.
Mercan M, Yayla V, Altinay S, Seyhan S. Peripheral neuropathy in Tangier disease: A literature review and assessment. J PeripherNerv Syst 2018; 23:88.
Lee J, Hegele RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management. J Inherit Metab Dis. 2014 May;37(3):333-9.
Finsterer J, Löscher WN, Wanschitz J, Iglseder S. Orphan Peripheral Neuropathies. J Neuromuscul Dis 2021;8(1):1-23.
Menezes MP, Ouvrier RA. Peripheral neuropathy associated with mitochondrial disease in children. Dev Med Child Neurol 2012; 54:407.
Kraemer KH, Patronas NJ, Schiffmann R, et al. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007; 145:1388.
Burns TM, Mauermann ML. The evaluation of polyneuropathies. Neurology. 2011;76(7 suppl 2):S6-13.
Jin PH, Shin SC. Neuropathy of Connective Tissue Diseases and Other Systemic Diseases. Semin Neurol. 2019;39:651-68.
Walter-Höliner I, Barbarini DS, Lütschg J, et al. High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study. Pediatr Neurol 2018; 80:51.
Khedr EM, El Toony LF, Tarkhan MN, Abdella G. Peripheral and central nervous system alterations in hypothyroidism: electrophysiological findings. Neuropsychobiology 2000; 41:88.
Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics 2004; 113:1672.
Al-Wahaibi AK, Kumar S, Al-Risi A, Wali F. Thyrotoxic Neuropathy: A rare cause of acute flaccid paraplegia. Sultan Qaboos Univ Med J. 2017;17:e460-e463
Gwathmey KG, Grogan J. Nutritional neuropathies. Muscle Nerve. 2020 Jul;62(1):13-29.
England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ; American Academy of Neurology. Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72: 185-92
Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (MinneapMinn) 2014;20:1293-1306
Anand P, Kharal GA, Reda H, Venna N. Peripheral Neuropathies in Infectious Diseases. Semin Neurol. 2019;39:640-50
Moore PM. Neurological manifestation of vasculitis: update on immunopathogenic mechanisms and clinical features. Ann Neurol 1995; 37 Suppl 1:S131.
Beachy N, Satkowiak K, Gwathmey KG. Vasculitic Neuropathies. Semin Neurol. 2019;39:608-19.
Mahmoud RA, Abrams CK. Acute demyelinating neuropathy in a patient with neurolymphomatosis. BMJ Case Rep. 2018;2018. pii: bcr-2017-222814.
Antoine JC, Camdessanche JP. Paraneoplastic neuropathies. CurrOpin Neurol. 2017;30:513-20.
Malek E, Salameh J. Guillain-Barre Syndrome. Semin Neurol. 2019;39:589-95.
Bourque PR, Chardon JW, Massie R. Autoimmune peripheral neuropathies. Clin Chim Acta. 2015;449:37-42.
Willison HJ, Jacobs BV, van Doorn PA. Guillain-Barré Syndrome. Lancet 2016; 388: 717-27
Hao Y, Wang W, Jacobs BC, Qiao B, Chen M, Liu D, Feng X, Wang Y. Antecedent infections in Guillain-Barre´ syndrome: A single-center, prospective study. Ann Clin Transl Neurol. 2019;6(12):2510-7.
Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study. Neuropediatrics 2007; 38:10.
Gregory MA, Gregory RJ, Podd JV. Understanding Guillain-Barre syndrome and central nervous system involvement. RehabilNurs. 2005 Sep-Oct;30(5):207-12.
Roodbol J, de Wit MY, van den Berg B, Kahlmann V, Drenthen J, Catsman-Berrevoets CE, Jacobs BC. Diagnosis of Guillain-Barre syndrome in children and validation of the Brighton criteria. J Neurol. 2017 May;264(5):856-861. doi: 10.1007/s00415-017-8429-8.
Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H, Bangalore Raja SK, Kothandapani S, Noroozpour Z, Aheta Sham M, Prasad N, Sunny SP, Mohammed MD, Gangadharappa R, Nidsale Sudarshan R. Guillain-Barre syndrome: clinical profile and management. Ger Med Sci. 2015 Sep 21;13:Doc16.
Estrade S, Guiomard C, Fabry V, et al. Prognostic factors for the sequelae and severity of Guillain-Barré syndrome in children. Muscle Nerve 2019; 60:716.
Bowyer HR, Glover M. Guillain-Barre syndrome: management and treatment options for patients with moderate to severe progression J NeurosciNurs. 2010 Oct;42(5):288-93.
Özkale M, Erol I, Özkale Y, Kozanoğlu İ. Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience. Acta Neurol Belg. 2018 Sep;118(3):451-458.
Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2014; :CD002063.
Shahar E, Leiderman M. Outcome of severe Guillain-Barré syndrome in children: comparison between untreated cases versus gamma-globulin therapy. Clin Neuropharmacol 2003; 26:84.
Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2012; 78:1009.
Lehmann HC, Burke D, Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):981-987.
Rodríguez Y, Vatti N, Ramírez-Santana C, Chang C, Mancera-Páez O, Gershwin ME, Anaya JM. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease. J Autoimmun. 2019 Aug;102:8-37.
